Missing Full Disclosures

For papers published in volume 10, issues 4–6, and volume 11, issue 1, full disclosures were missing online. The affected papers are listed below. This was a result of an error during migration to the current submissions platform. The editorial office regrets the absence of the full disclosures, which are now restored.

• “Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies” by Serrano-Castro et al.¹

• “EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls” by Monaco et al.²

• “Frequency and Referral Patterns of Neural Antibody Studies During the COVID-19 Pandemic: Experience From an Autoimmune Neurology Center” by Ariño et al.³

• “IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation” by Cao et al.⁴

• “Increased Intracranial Pressure in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease” by Nguyen et al.⁵

• “LGI1 Encephalitis and IgG4-Related Disease: Rare Conditions Collide” by Jesuthasan et al.⁶

• “Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis Criteria” by Van Steenhoven et al.⁷

• “Prevalence, Clinical Profiles, and Prognosis of Stiff-Person Syndrome in a Japanese Nationwide Survey” by Matsui et al.⁸

• “Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis” by Thebault et al.⁹

• “Structural Changes of Cutaneous Immune Cells in Patients With Type 1 Diabetes and Their Relationship With Diabetic Polyneuropathy” by Hu et al.¹⁰

• “Subacute Horizontal Diplopia, Jaw Dystonia, and Laryngospasm” Tisavipat et al.¹¹

• “Visual System Involvement in Glial Fibrillary Acidic Protein Astrocytopathy: Two Case Reports and a Systematic Literature Review” by Greco et al.¹²